Canada, November 29, 2019 (CISION)- Announces intent to initiate Phase 1 first-in-human safety and tolerability trials for its lead candidate, PP 101 micro-PEA during 1Q20 – – Raises $4.59 million in additional capital at $20.10 per share – TORONTO, Nov. 29, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) today reported financial …Read More »
Tag Archives: FSDPharma
FSD PHARMA SECOND TRANCHE OF PRIVATE PLACEMENT CLOSES, TOTAL OF $4.59 MILLION RAISED AT $20.10 TO DATE, EXTENDS OFFERING
TORONTO, November 4, 2019 – (FSD Pharma Inc.) (CSE: HUGE) (OTCQB: FSDDD) (FRA: 0K9) (“FSD” or the “Company“) announces that it has closed a second tranche of its previously announced private placement (the “Private Placement“), and has now raised total gross proceeds of CAD $4,596,285 from investors, including members of senior management …Read More »
TORONTO, October 23, 2019 – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”) announces that an amended and restated management’s discussion and analysis for the year ended December 31, 2018 (the “Amended 2018 MD&A“) has been filed on SEDAR to better comply with National Instrument …Read More »
In early 2019, the leadership at FSD Pharma Inc. (CSE: HUGE, OTCQB: FSDDD, Forum) realized that the nascent cannabis industry in Canada is heading into a supply gut and a major shortfall in sales. The medical research and development Company terminated its joint venture agreement with Auxly Cannabis Group Inc. (TSX-V: XLY), which was a controversial move, but …Read More »
Canada, October 17, 2019 (INVESTMENT PITCH MEDIA) The temporary change is protocol for stocks that trade on US exchanges that undergo structural events, such as the recent share consolidation of one new share for each 201 old shares, announced by FSD Pharma on October 11th, in order to advance the company’s …Read More »
FSD Pharma announced that the Company’s Class B Shares are trading on the OTCQB under the ticker symbol FSDDD
TORONTO, Oct. 17, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDD) (FRA: 0K9) (“FSD” or the “Company”) today announced that the Company’s Class B Shares are trading on the OTCQB under the ticker symbol FSDDD for 20 business days, effective as of October 16, 2019. On November 13, 2019, the OTCQB symbol …Read More »
A glance at some of the day’s highlights from the Proactive Investors US and Canada newswires October 11, 2019 (PROACTIVE)- Medallion Resources Ltd. – Medallion Resources Ltd (CVE:MDL) (OTCMKTS:MLLOF) announced another step in its development Friday, having raised a total of C$794,874 in a private placing to advance the business. The …Read More »
FSD PHARMA APPOINTS FORMER MEMBER OF U.S. CONGRESS TO ITS BOARD OF DIRECTORS, ANNOUNCES SHARE CONSOLIDATION
TORONTO, October 11, 2019 – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”) today announced the appointment of former U.S. congressman Stephen Buyer to the Company’s Board of Directors. The Company also announced that it will complete a consolidation of its class A multiple voting …Read More »
TORONTO, October 1, 2019 – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company“) is pleased to provide an update on its previously announced private placement of its class B subordinate voting shares (“Shares”) at a price of CAD$0.10 per Share (the “Private Placement”). On September 30, 2019, …Read More »
U.K., October 1, 2019 (PROACTIVE)- It said the first tranche raised gross proceeds of C$4,583,085 from investors, issuing an aggregate of 45,830,850 shares at a price of C$0.10 each. The group noted that net proceeds from the private placement will be used for the expansion of the company’s biosciences division. …Read More »
Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!